サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1769571

人工多能性幹細胞（iPSC）の世界市場の機会と2034年までの戦略

Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2034

出版日
ページ情報
英文 346 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
人工多能性幹細胞（iPSC）の世界市場の機会と2034年までの戦略
出版日: 2025年07月09日
発行: The Business Research Company
ページ情報: 英文 346 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の人工多能性幹細胞（IPSC）市場は2019年に11億7,805万米ドルと評価され、2024年まで10.00％以上のCAGRで成長しました。

遺伝性疾患の有病率の上昇

実績期間中、遺伝性疾患の有病率の上昇が人工多能性幹細胞（iPSC）市場の成長を支えました。iPSCは患者特異的モデルの作成を可能にし、嚢胞性線維症やデュシェンヌ型筋ジストロフィーのような疾患の研究を加速させています。さらに、iPSCはCRISPR-Cas9のような遺伝子編集技術のプラットフォームとして機能し、遺伝性疾患の治療の可能性を記載しています。健康な組織を生成する能力を持つiPS細胞は、再生医療、特に変性疾患や臓器機能不全の治療において重要性を増しています。例えば、2023年2月に英国遺伝同盟が発表した記事によると、推定では25人に1人の割合で遺伝疾患が発症するといいます。これは、英国では毎年3万人の赤ちゃんと幼児が新たに診断され、240万人以上の幼児と成人が遺伝子疾患を抱えていることを意味します。したがって、遺伝性疾患の有病率の上昇が人工多能性幹細胞（iPSC）市場の成長を牽引しました。

目次

第1章 エグゼクティブサマリー

  • 人工多能性幹細胞（iPSC）-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • 人工多能性幹細胞（iPSC）市場定義とセグメンテーション
  • 派生細胞タイプ別市場セグメンテーション
    • 肝細胞
    • 線維芽細胞
    • ケラチノサイト
    • 羊膜細胞
    • その他の派生細胞タイプ
  • 市場セグメンテーション：用途別
    • 学術研究
    • 創薬と毒性研究
    • 再生医療
    • 細胞と遺伝子治療
  • 市場セグメンテーション：エンドユーザー別
    • 学術研究機関
    • 製薬とバイオテクノロジー企業
    • その他

第7章 主要な市場動向

  • すぐに使えるiPSC細胞株が、既製の細胞治療への道を開く
  • 革新的なiPSCベースのがん治療が巨額の投資により前進
  • 標準化されたiPSC細胞株が治療開発の効率を高める
  • 戦略的提携により遺伝子編集iPSCの商業化を目指す
  • ヒトiPSCベースのBBBモデルを用いた中枢神経系医薬品開発の推進

第8章 世界のな人工多能性幹細胞（iPSC）増殖分析と戦略分析フレームワーク

  • 世界：PESTEL分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 最終用途産業（B2B）の分析
    • 製薬とバイオテクノロジー企業
    • 学術研究機関
    • その他
  • 世界の人工多能性幹細胞（iPSC）市場：成長率分析
  • 市場成長実績、2019～2024年
    • 市場促進要因、2019～2024年
    • 市場抑制要因、2019～2024年
  • 市場成長予測、2024～2029年、2034年
  • 成長予測の貢献要因
    • 量的成長の貢献要因
    • 促進要因
    • 抑制要因
  • 全身誘導多能性幹細胞（iPSC）：総潜在市場規模（TAM）

第9章 世界の人工多能性幹細胞（iPSC）市場：セグメンテーション

  • 世界の人工多能性幹細胞（iPSC）市場：派生細胞タイプ別、実績と予測、2019～2024年、2029年、2034年
  • 世界の人工多能性幹細胞（iPSC）市場：用途別、実績と予測、2019～2024年、2029年、2034年
  • 世界の人工多能性幹細胞（iPSC）市場：エンドユーザー別、実績と予測、2019～2024年、2029年、2034年
  • 世界の人工多能性幹細胞（iPSC）市場、肝細胞のサブセグメンテーション、実績と予測、2019～2024年、2029年、2034年
  • 世界の人工多能性幹細胞（iPSC）市場、線維芽細胞のサブセグメンテーション、実績と予測、2019～2024年、2029年、2034年
  • 世界の人工多能性幹細胞（iPSC）市場、ケラチノサイトのサブセグメンテーション、実績と予測、2019～2024年、2029年、2034年
  • 世界の人工多能性幹細胞（iPSC）市場、羊膜細胞によるサブセグメンテーション、サブセグメンテーション、実績と予測、2019～2024年、2029年、2034年
  • 世界の人工多能性幹細胞（iPSC）市場、その他の派生細胞によるサブセグメンテーション、実績と予測、2019～2024年、2029年、2034年

第10章 人工多能性幹細胞（iPSC）市場：地域・国別分析

  • 世界の人工多能性幹細胞（iPSC）市場：地域別、実績と予測、2019～2024年、2029年、2034年
  • 世界の人工多能性幹細胞（iPSC）市場：国別、実績と予測、2019～2024年、2029年、2034年

第11章 アジア太平洋市場

第12章 西欧市場

第13章 東欧市場

第14章 北米市場

第15章 南米市場

第16章 中東市場

第17章 アフリカ市場

第18章 競合情勢と企業プロファイル

  • 企業プロファイル
  • FUJIFILM Holdings Corporation（FUJIFILM Cellular Dynamics, Inc）.
  • Thermo Fisher Scientific Inc.
  • STEMCELL Technologies Inc.
  • Lonza Group AG
  • Miltenyi BIoTec GmbH

第19章 その他の主要企業

  • Takara Bio Inc.
  • Astellas Pharma Inc.
  • Fate Therapeutics Inc.
  • ViaCyte Inc.
  • Sartorius
  • Shanghai Cell Therapy Group Ltd.
  • Ncardia
  • REPROCELL USA Inc.
  • Applied StemCells Inc.
  • Treefrog Therapeutics Inc.
  • Japan Tissue Engineering Co. Ltd.
  • DefiniGEN
  • Merck KGaA
  • iXCells Biotechnologies Inc.
  • Cynata Therapeutics Limited

第20章 競合ベンチマーキング

第21章 競合ダッシュボード

第22章 主要な合併と買収

  • Shineco Acquired InfiniClone Ltd
  • Axol Bioscience Ltd Acquired Phenocell SAS
  • Century Therapeutics Acquired Clade Therapeutics
  • QHP Capital Acquired Applied StemCell
  • Vertex Pharmaceuticals Acquired ViaCyte
  • Medipost Acquired OmniaBio

第23章 最近の動向人工多能性幹細胞（iPSC）市場

第24章 機会と戦略

  • 世界の人工多能性幹細胞（iPSC）市場、2029年：新たな機会を提供する国
  • 世界の人工多能性幹細胞（iPSC）市場、2029年：新たな機会を提供するセグメント
  • 世界の人工多能性幹細胞（iPSC）市場、2029年：成長戦略
    • 市場動向による戦略
    • 競合の戦略

第25章 人工多能性幹細胞（iPSC）市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人材

第26章 付録

目次
Product Code: o&s1695

Induced pluripotent stem cells (iPSC), are a type of artificial stem cells that are pluripotent, which can give rise to several different cell types, but are produced directly from somatic cells.

The induced pluripotent stem cell (IPSC) market consists of the sales of induced pluripotent stem cell (IPSC) by entities (organizations, sole traders, and partnerships) that are derived from adult somatic cells such as fibroblasts or blood cells that have been reprogrammed into pluripotent stem cells by the introduction of a set of transcription factors linked to pluripotency. The resulting iPSCs can then be differentiated into a variety of cell types, such as cardiomyocytes, neuronal cells, hepatocytes and hematopoietic cells, using in vitro differentiation protocols.

The global induced pluripotent stem cell (IPSC) market was valued at $1,178.05 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 10.00%.

Rising Prevalence Of Genetic Disorders

During the historic period, the rising prevalence of genetic disorders supported the growth of the induced pluripotent stem cell (iPSC) market. The rising prevalence of genetic disorders has heightened the need for advanced models to study these conditions. iPSCs enable the creation of patient-specific models, accelerating research into diseases like cystic fibrosis and Duchenne muscular dystrophy. Additionally, iPSCs serve as a platform for gene editing technologies, such as CRISPR-Cas9, offering potential treatments for genetic disorders. With their ability to generate healthy tissues, iPSCs are becoming increasingly important in regenerative medicine, particularly for treating degenerative conditions and organ dysfunction. For instance, in February 2023, according to an article published by Genetic Alliance UK, according to estimates, the genetic condition affects 1 in every 25 children. This implies that 30,000 babies and children are newly diagnosed in the UK annually and more than 2.4 million children and adults have a genetic disorder. Therefore, the rising prevalence of genetic disorders drove the growth of the induced pluripotent stem cell (iPSC) market.

Innovative iPSC-Based Cancer Therapy Moves Forward With Significant Investment

Major companies operating in the induced pluripotent stem cell (iPSC) market are strategically investing by focusing on the development of advanced cell culture systems and tools to improve iPSC generation, differentiation and characterization processes. They are actively working on optimizing production methods for higher efficiency and scalability, addressing challenges in regulatory compliance and developing new applications in drug discovery, regenerative medicine and disease modeling. For example, in August 2024, Shinobi Therapeutics, a US-based biotechnology company pioneering the development of off-the-shelf, immune-evasive cell therapies derived from induced pluripotent stem cells (iPSCs), secured a non-dilutive grant of up to $59 million from the Japanese Agency for Medical Research and Development (AMED) to advance its lead iPS-T cell therapy targeting GPC3-positive solid tumors. This funding will support the development of Shinobi's immune-evasive iPSC-derived T cell therapies, which aim to provide scalable, off-the-shelf treatments for cancer patients.

The global induced pluripotent stem cell (iPSC) market is fairly concentrated, with large number of small players operating in the market. The top ten competitors in the market made up to 30.52% of the total market in 2023.

Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global induced pluripotent stem cells (iPSC) market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for induced pluripotent stem cells (iPSC)? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The induced pluripotent stem cells (iPSC) market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider induced pluripotent stem cells (iPSC) market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by derived cell type, by application and by end-user.
  • Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Global Market Size And Growth- Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by derived cell type, by application and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Recent Developments- Information on recent developments in the market covered in the report.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for induced pluripotent stem cells (iPSC) providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Derived Cell Type: Hepatocytes; Fibroblasts; Keratinocytes; Amniotic Cells; Other Derived Cell Types
  • 2) By Application: Academic Research; Drug Discovery And Toxicity Studies; Regenerative Medicine; Cell And Gene Therapy
  • 3) By End-User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Other End Users
  • Companies Mentioned: FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc); Thermo Fisher Scientific Inc.; STEMCELL Technologies Inc.; Lonza Group AG; Miltenyi Biotec GmbH
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; induced pluripotent stem cells (iPSC) indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Induced Pluripotent Stem Cell (iPSC) - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Induced Pluripotent Stem Cell (iPSC) Market Definition And Segmentations
  • 6.4 Market Segmentation By Derived Cell Type
    • 6.4.1 Hepatocytes
    • 6.4.2 Fibroblasts
    • 6.4.3 Keratinocytes
    • 6.4.4 Amniotic Cells
    • 6.4.5 Other Derived Cell Types
  • 6.5 Market Segmentation By Application
    • 6.5.1 Academic Research
    • 6.5.2 Drug Discovery And Toxicity Studies
    • 6.5.3 Regenerative Medicine
    • 6.5.4 Cell And Gene Therapy
  • 6.6 Market Segmentation By End-User
    • 6.6.1 Academic And Research Institutes
    • 6.6.2 Pharmaceutical And Biotechnology Companies
    • 6.6.3 Other End Users

7 Major Market Trends

  • 7.1 Ready-To-Use iPSC Cell Lines Pave Way For Off-The-Shelf Cell Therapies
  • 7.2 Innovative iPSC-Based Cancer Therapy Moves Forward With Significant Investment
  • 7.3 Standardized iPSC Lines Enhance Efficiency In Therapeutic Development
  • 7.4 Strategic Partnership Targets Commercialization Of Gene-Edited iPSCs
  • 7.5 Advancing CNS Drug Development With Human iPSC-Based BBB Models

8 Global Induced Pluripotent Stem Cell (iPSC) Growth Analysis And Strategic Analysis Framework

  • 8.1 Global: PESTEL Analysis
    • 8.1.1 Political
    • 8.1.2 Economic
    • 8.1.3 Social
    • 8.1.4 Technological
    • 8.1.5 Environmental
    • 8.1.6 Legal
  • 8.2 Analysis Of End Use Industries (B2B)
    • 8.2.1 Pharmaceutical And Biotechnology Companies
    • 8.2.2 Academic And Research Institutes
    • 8.2.3 Other End Users
  • 8.3 Global Induced Pluripotent Stem Cell (iPSC) Market Growth Rate Analysis
  • 8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
    • 8.4.1 Market Drivers 2019 - 2024
    • 8.4.2 Market Restraints 2019 - 2024
  • 8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
  • 8.6 Forecast Growth Contributors/Factors
    • 8.6.1 Quantitative Growth Contributors
    • 8.6.2 Drivers
    • 8.6.3 Restraints
  • 8.7 Global Induced Pluripotent Stem Cell (iPSC) Total Addressable Market (TAM)

9 Global Induced Pluripotent Stem Cell (iPSC) Market Segmentation

  • 9.1 Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.2 Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.3 Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.4 Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Hepatocytes, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.5 Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Fibroblasts, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.6 Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Keratinocytes, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.7 Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation By Amniotic Cells, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.8 Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation By Other Derived Cells, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Induced Pluripotent Stem Cell (iPSC) Market, Regional and Country Analysis

  • 10.1 Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.2 Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

  • 11.1 Summary
  • 11.2 Market Overview
    • 11.2.1 Region Information
    • 11.2.2 Market Information
    • 11.2.3 Background Information
    • 11.2.4 Government Initiatives
    • 11.2.5 Regulations
    • 11.2.6 Regulatory Bodies
    • 11.2.7 Major Associations
    • 11.2.8 Taxes Levied
    • 11.2.9 Corporate Tax Structure
    • 11.2.10 Investments
    • 11.2.11 Major Companies
  • 11.3 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.4 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.5 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.6 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
  • 11.7 China Market
  • 11.8 Summary
  • 11.9 Market Overview
    • 11.9.1 Country Information
    • 11.9.2 Market Information
    • 11.9.3 Background Information
    • 11.9.4 Government Initiatives
    • 11.9.5 Regulations
    • 11.9.6 Regulatory Bodies
    • 11.9.7 Major Associations
    • 11.9.8 Taxes Levied
    • 11.9.9 Corporate Tax Structure
    • 11.9.10 Investments
    • 11.9.11 Major Companies
  • 11.10 China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.11 China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.12 China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.13 India Market
  • 11.14 India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.15 India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.16 India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.17 Japan Market
  • 11.18 Summary
  • 11.19 Market Overview
    • 11.19.1 Country Information
    • 11.19.2 Market Information
    • 11.19.3 Background Information
    • 11.19.4 Government Initiatives
    • 11.19.5 Regulations
    • 11.19.6 Regulatory Bodies
    • 11.19.7 Major Associations
    • 11.19.8 Taxes Levied
    • 11.19.9 Corporate Tax Structure
    • 11.19.10 Investments
    • 11.19.11 Major Companies
  • 11.20 Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.21 Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.22 Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.23 South Korea Market
  • 11.24 Summary
  • 11.25 Market Overview
    • 11.25.1 Country Information
    • 11.25.2 Market Information
    • 11.25.3 Background Information
    • 11.25.4 Government Initiatives
    • 11.25.5 Regulations
    • 11.25.6 Regulatory Bodies
    • 11.25.7 Major Associations
    • 11.25.8 Taxes Levied
    • 11.25.9 Corporate Tax Structure
    • 11.25.10 Investments
    • 11.25.11 Major Companies
  • 11.26 South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.27 South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.28 South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.29 Australia Market
  • 11.30 Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.31 Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.32 Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.33 Indonesia Market
  • 11.34 Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.35 Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.36 Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate tax structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.4 Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.5 Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.6 Western Europe Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
  • 12.7 UK Market
  • 12.8 UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.9 UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.10 UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.11 Germany Market
  • 12.12 Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.13 Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.14 Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.15 France Market
  • 12.16 France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.17 France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.18 France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.19 Italy Market
  • 12.20 Italy Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.21 Italy Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.22 Italy Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.23 Spain Market
  • 12.24 Spain Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.25 Spain Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.26 Spain Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Investments
    • 13.2.11 Major Companies
  • 13.3 Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.4 Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.5 Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.6 Russia Market
  • 13.7 Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.8 Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.9 Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Investments
    • 14.2.11 Major Companies
  • 14.3 North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.4 North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.5 North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.6 USA Market
  • 14.7 Summary
  • 14.8 Market Overview
    • 14.8.1 Country Information
    • 14.8.2 Market Information
    • 14.8.3 Background Information
    • 14.8.4 Government Initiatives
    • 14.8.5 Regulations
    • 14.8.6 Regulatory Bodies
    • 14.8.7 Major Associations
    • 14.8.8 Taxes Levied
    • 14.8.9 Corporate Tax Structure
    • 14.8.10 Investments
    • 14.8.11 Major Companies
  • 14.9 USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.10 USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.11 USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.12 Canada Market
  • 14.13 Summary
  • 14.14 Market Overview
    • 14.14.1 Country Information
    • 14.14.2 Market Information
    • 14.14.3 Background Information
    • 14.14.4 Government Initiatives
    • 14.14.5 Regulations
    • 14.14.6 Regulatory Bodies
    • 14.14.7 Major Associations
    • 14.14.8 Taxes Levied
    • 14.14.9 Corporate Tax Structure
    • 14.14.10 Investments
    • 14.14.11 Major Companies
  • 14.15 Canada Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.16 Canada Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.17 Canada Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.4 South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.5 South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.6 Brazil Market
  • 15.7 Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.8 Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.9 Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investments
    • 16.2.11 Major Companies
  • 16.3 Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.4 Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.5 Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Major Companies
  • 17.3 Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.4 Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.5 Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

  • 18.1 Company Profiles
  • 18.2 FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc).
    • 18.2.1 Company Overview
    • 18.2.2 Products And Services
    • 18.2.3 Business Strategy
    • 18.2.4 Financial Overview
  • 18.3 Thermo Fisher Scientific Inc.
    • 18.3.1 Company Overview
    • 18.3.2 Products And Services
    • 18.3.3 Business Strategy
    • 18.3.4 Financial Overview
  • 18.4 STEMCELL Technologies Inc.
    • 18.4.1 Company Overview
    • 18.4.2 Products And Services
    • 18.4.3 Business Strategy
    • 18.4.4 Financial Overview
  • 18.5 Lonza Group AG
    • 18.5.1 Company Overview
    • 18.5.2 Products And Services
    • 18.5.3 Financial Overview
  • 18.6 Miltenyi Biotec GmbH
    • 18.6.1 Company Overview
    • 18.6.2 Products And Services
    • 18.6.3 Financial Overview

19 Other Major Companies

  • 19.1 Takara Bio Inc.
    • 19.1.1 Company Overview
    • 19.1.2 Products And Services
  • 19.2 Astellas Pharma Inc.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
  • 19.3 Fate Therapeutics Inc.
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
  • 19.4 ViaCyte Inc.
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
  • 19.5 Sartorius
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
  • 19.6 Shanghai Cell Therapy Group Ltd.
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
  • 19.7 Ncardia
    • 19.7.1 Company Overview
    • 19.7.2 Products And Services
  • 19.8 REPROCELL USA Inc.
    • 19.8.1 Company Overview
    • 19.8.2 Products And Services
  • 19.9 Applied StemCells Inc.
    • 19.9.1 Company Overview
    • 19.9.2 Products And Services
  • 19.10 Treefrog Therapeutics Inc.
    • 19.10.1 Company Overview
    • 19.10.2 Products And Services
  • 19.11 Japan Tissue Engineering Co. Ltd.
    • 19.11.1 Company Overview
    • 19.11.2 Products And Services
  • 19.12 DefiniGEN
    • 19.12.1 Company Overview
    • 19.12.2 Products And Services
  • 19.13 Merck KGaA.
    • 19.13.1 Company Overview
    • 19.13.2 Products And Services
  • 19.14 iXCells Biotechnologies Inc.
    • 19.14.1 Company Overview
    • 19.14.2 Products And Services
  • 19.15 Cynata Therapeutics Limited
    • 19.15.1 Company Overview
    • 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Shineco Acquired InfiniClone Ltd
  • 22.2 Axol Bioscience Ltd Acquired Phenocell SAS
  • 22.3 Century Therapeutics Acquired Clade Therapeutics
  • 22.4 QHP Capital Acquired Applied StemCell
  • 22.5 Vertex Pharmaceuticals Acquired ViaCyte
  • 22.6 Medipost Acquired OmniaBio

23 Recent Developments In The Induced Pluripotent Stem Cell (iPSC) Market

  • 23.1 Revolutionary Stem Cell Banking Brings Personalized Regenerative Care To The Masses
  • 23.2 Next-Generation NK Cell Therapy Platform Enhances Clinical Readiness
  • 23.3 Revolutionizing Cardiovascular Care With Personalized iPSC Solutions
  • 23.4 AI-Powered iPSC Foundry Improving Outcomes For Parkinson's Patients

24 Opportunities And Strategies

  • 24.1 Global Induced Pluripotent Stem Cell (iPSC) Market In 2029 - Countries Offering Most New Opportunities
  • 24.2 Global Induced Pluripotent Stem Cell (iPSC) Market In 2029 - Segments Offering Most New Opportunities
  • 24.3 Global Induced Pluripotent Stem Cell (iPSC) Market In 2029 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Induced Pluripotent Stem Cell (iPSC) Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer